Skip to main content
. Author manuscript; available in PMC: 2022 Jun 1.
Published in final edited form as: Pharmacol Ther. 2020 Dec 14;222:107788. doi: 10.1016/j.pharmthera.2020.107788

Table 1-.

A comparative review of G6PD diagnostic tests

Gold
Standard
Fluorescent
Spot
Test
CareStart™
RDT
CareStart™
G6PD
Biosensor
STANDARD™
G6PD
by SD
Biosensor
“Sample
-to-
readout”
BS-240
Method Spectrophotometry UV fluorescence visualization Colorization chamber Biosensor, test strip Biosensor, test strip Colorization, fabricated biosensor Automated UV enzyme system
Volume 10μL 5μL 2μL 5μL 10μL 15μL 20μL
Blood Venous Venous Whole Whole Venous or capillary Whole Hemolys ate venous blood
Time 5-10 min 10 min + air dry time 10 min 4 min 2 min 10 min + air dry time 2 min
Temperature 30°C Room temperature Variable Room temperature Variable Room temperature 37°C
Intermediate Reading* Yes No No Yes Yes Yes No
Measurement Quantitative Qualitative Qualitative Quantitative Quantitative Qualitative Quantitative
Sensitivity # Very High Med-High Med-High High High Med-High Med-High
Specificity # Very High Med-High Med-High High High Med-High Med-High
Diagnostic Accuracy# Very High Low-Med Medium High Very High Med-High Low-Med
*

Intermediate readout for the G6PD activity is important for diagnosis on mild/intermediate G6PD deficiency. This provides the scope for determining threshold of G6PD deficiency for safety of therapeutics in G6PD deficient populations.

#

The performance of individual methods of diagnosis of G6PD deficiency regarding sensitivity, specificity, and diagnostic accuracy is subjective and may not be compared quantitatively.